February 22, 2024

Medical Trend

Medical News and Medical Resources

Japan Reports First Death from Monkeypox

Japan Reports First Death from Monkeypox

Japan Reports First Death from Monkeypox, a 30-Year-Old Man with Immunodeficiency, According to the Ministry of Health

Ministry of Health Reveals Details of the First Fatal Case of Monkeypox Infection in Japan.

The Ministry of Health in Japan has announced the first confirmed death from an infection of “Monkeypox,” a disease with symptoms similar to smallpox. 


What did the Ministry of Health announce?

On December 13, 2023, the Ministry of Health announced the death of a man infected with Monkeypox.

According to the ministry, the deceased was a man in his 30s living in Saitama Prefecture. Monkeypox infection was confirmed in September 2023, and his death was confirmed in November 2023.


The man had no history of international travel but was infected with HIV (Human Immunodeficiency Virus), leading to immunodeficiency. This marks the first confirmed death of a Monkeypox-infected patient in Japan.

Monkeypox has been spreading since May 2022, mainly in Europe and the Americas, with the first case reported in Japan in July 2022. As of December 3, 2023, there have been 227 confirmed cases.

Formerly known as Monkeypox, the Ministry of Health changed the name to Monkeypox in May 2023 following the recommendation of the World Health Organization (WHO).

Monkeypox can be transmitted through contact with the bodily fluids or blood of an infected person or animal, as well as prolonged exposure to droplets at close range. The Ministry of Health advises basic infection prevention measures such as hand hygiene and encourages consulting nearby medical facilities if there are abnormal symptoms such as fever or rash.


What is Monkeypox?

Monkeypox is an acute rash illness caused by the Monkeypox virus, primarily occurring in Central to West Africa.

Common symptoms include fever and rash, and in most cases, the illness naturally resolves within 2 to 4 weeks. However, there have been reports of severe cases and deaths, particularly in children.

Transmission of the Monkeypox virus occurs through bites from infected animals, as well as contact with blood or rash. While human-to-human transmission is rare, there have been reports of infections among close contacts and healthcare workers via contact with the patient’s droplets, bodily fluids, or rash through linen.

The incubation period for Monkeypox is 6 to 13 days, with symptoms such as fever, headache, swollen lymph nodes, and muscle aches lasting 0 to 5 days. Rash appears 1 to 3 days after fever onset.

However, it’s essential to note that not all cases show preceding symptoms like fever, headache, or swollen lymph nodes, requiring careful attention.


How should we interpret this announcement?

Regarding the recent announcement by the Ministry of Health about the death of a Monkeypox-infected individual, what insights can you provide?

Firstly, we express our condolences for the deceased. In this case, the compromised immune system of the individual played a significant role in the fatal outcome. While Monkeypox itself has a low mortality rate, individuals with weakened immune systems are at a higher risk of severe complications and death.

Those with immunodeficiency disorders, acquired immunodeficiency syndrome (AIDS), and pregnant individuals should be cautious. If Monkeypox is suspected due to symptoms like fever and rash, prompt medical attention, diagnosis, and treatment are crucial.



In conclusion

On December 13, 2023, the Ministry of Health revealed the first confirmed death from Monkeypox infection in Japan.

While many Monkeypox cases result in a mild course, severe cases and deaths can occur, especially in children, pregnant women, and immunocompromised individuals.

This recent fatality is likely to draw attention to the ongoing situation.


Japan Reports First Death from Monkeypox

Japan Reports First Death from Monkeypox

(source:internet, reference only)

Disclaimer of medicaltrend.org

Important Note: The information provided is for informational purposes only and should not be considered as medical advice.